Opthocare MONO (Tobramycin 0.3%) is a broad-spectrum ophthalmic solution designed to effectively combat bacterial infections while addressing antibiotic resistance. It provides targeted treatment for secondary infections, MRS keratitis, eyelid diseases, and eye discharge. Additionally, Opthocare MONO offers post-surgical benefits in conditions like cherry eye, ensuring safe and reliable care. Its potent yet gentle formulation makes it an excellent choice for maintaining optimal eye health.
Secondary infection
Post surgical benefits in cherry eyes
MRS keratitis
Eyelid disease
Eye discharge
Opthocare MONO is available in a single, carefully optimized formulation with Tobramycin 0.3%, ensuring the perfect balance of efficacy and safety. This concentration provides broad-spectrum antibacterial action, effectively combating infections while minimizing the risk of resistance. The single variation simplifies usage and ensures consistent results, making it the best choice for treating secondary infections, post-surgical care, and conditions like MRS keratitis, eyelid disease, and eye discharge.
Opthocare MONO contains Tobramycin 0.3%, a potent aminoglycoside antibiotic effective against a wide range of gram-positive and gram-negative bacteria. Its mechanism of action disrupts bacterial protein synthesis, ensuring rapid and reliable infection control.
Tobramycin's advanced formulation targets resistant strains like methicillin-resistant Staphylococcus (MRS) keratitis, making it a valuable solution in combating challenging ocular infections while reducing the development of antibiotic resistance.
Opthocare MONO’s formulation is designed to be safe and non-irritating, making it ideal for post-surgical care, such as in cherry eye procedures. Its efficacy in managing eyelid diseases and eye discharge further highlights its suitability for sensitive applications.
Q
What is Opthocare MONO used for?
A
Opthocare MONO is used to treat bacterial eye infections, including secondary infections, MRS keratitis, eyelid diseases, and eye discharge. It also provides post-surgical benefits for conditions like cherry eye.
Q
How does Opthocare MONO work?
A
Opthocare MONO contains Tobramycin 0.3%, which acts by inhibiting bacterial protein synthesis, effectively eliminating a wide range of bacteria and preventing antibiotic resistance.
Q
Is Opthocare MONO safe for post-surgical care?
A
Yes, Opthocare MONO is formulated to be safe and effective for post-surgical care, such as after cherry eye procedures, ensuring infection control and promoting recovery.
